BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mallah SI, Ghorab OK, Al-Salmi S, Abdellatif OS, Tharmaratnam T, Iskandar MA, Sefen JAN, Sidhu P, Atallah B, El-Lababidi R, Al-Qahtani M. COVID-19: breaking down a global health crisis. Ann Clin Microbiol Antimicrob 2021;20:35. [PMID: 34006330 DOI: 10.1186/s12941-021-00438-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 El Sharif H, Dennison S, Tully M, Crossley S, Mwangi W, Bailey D, Graham S, Reddy S. Evaluation of electropolymerized molecularly imprinted polymers (E-MIPs) on disposable electrodes for detection of SARS-CoV-2 in saliva. Analytica Chimica Acta 2022;1206:339777. [DOI: 10.1016/j.aca.2022.339777] [Reference Citation Analysis]
2 Beleva N. Change in hospital admissions in dental diseases before and during the COVID-19 pandemic. Appl Nanosci. [DOI: 10.1007/s13204-021-02106-w] [Reference Citation Analysis]
3 Wu L, Wang X, Li R, Huang Z, Guo X, Liu J, Yan H, Sun X. Willingness to Receive a COVID-19 Vaccine and Associated Factors among Older Adults: A Cross-Sectional Survey in Shanghai, China. Vaccines 2022;10:654. [DOI: 10.3390/vaccines10050654] [Reference Citation Analysis]
4 Kreiser T, Zaguri D, Sachdeva S, Zamostiano R, Mograbi J, Segal D, Bacharach E, Gazit E. Inhibition of Respiratory RNA Viruses by a Composition of Ionophoric Polyphenols with Metal Ions. Pharmaceuticals 2022;15:377. [DOI: 10.3390/ph15030377] [Reference Citation Analysis]
5 Cunningham ET, Zierhut M. SARS-CoV-2, COVID-19, and the Eye. Ocul Immunol Inflamm 2021;29:629-30. [PMID: 34596492 DOI: 10.1080/09273948.2021.1970423] [Reference Citation Analysis]
6 Tuli HS, Sak K, Aggarwal P, Iqubal A, Upadhaya SK, Kaur J, Kaur G, Aggarwal D. Molecular Evolution of Severe Acute Respiratory Syndrome Coronavirus 2: Hazardous and More Hazardous Strains Behind the Coronavirus Disease 2019 Pandemic and Their Targeting by Drugs and Vaccines. Front Cell Infect Microbiol 2021;11:763687. [PMID: 34970505 DOI: 10.3389/fcimb.2021.763687] [Reference Citation Analysis]
7 Rejinold N S, Choi G, Piao H, Choy JH. Bovine Serum Albumin-Coated Niclosamide-Zein Nanoparticles as Potential Injectable Medicine against COVID-19. Materials (Basel) 2021;14:3792. [PMID: 34300711 DOI: 10.3390/ma14143792] [Reference Citation Analysis]
8 Llor C, Ouchi D, Giner-Soriano M, García-Sangenís A, Bjerrum L, Morros R. Correlation between Previous Antibiotic Exposure and COVID-19 Severity. A Population-Based Cohort Study. Antibiotics (Basel) 2021;10:1364. [PMID: 34827302 DOI: 10.3390/antibiotics10111364] [Reference Citation Analysis]
9 Quintero GA. The response to the COVID-19 pandemic trusted in pharmacovigilance to diminish communication risk. Therapeutic Advances in Drug Safety 2022;13:204209862210886. [DOI: 10.1177/20420986221088650] [Reference Citation Analysis]
10 Abdel-Aziz HR, Atia NS. Respiratory Infections Prevention in Rural Older Adults: An Interventional Study. Clin Nurs Res 2022;:10547738221081981. [PMID: 35285282 DOI: 10.1177/10547738221081981] [Reference Citation Analysis]
11 El Minawi H, Abdelgawad A, El Saloussy Y, Abdelgawad BA. Postoperative Cutaneous Manifestations as the First Presentation of COVID-19 Infection or a Postvaccination Sequel. Plast Reconstr Surg Glob Open 2022;10:e4163. [PMID: 35223348 DOI: 10.1097/GOX.0000000000004163] [Reference Citation Analysis]
12 Unver S, Haholu A, Yildirim S. Nephrotic syndrome and acute kidney injury following CoronaVac anti-SARS-CoV-2 vaccine. Clinical Kidney Journal 2021;14:2608-11. [DOI: 10.1093/ckj/sfab155] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Infantino M, Manfredi M, Stacchini L, Cosma C, Grossi V, Lari B, Russo E, Amedei A, Benucci M, Veneziani F, Casprini P, Catalano CM, Cirrincione G, Bonaccorsi G, Pompetti A. The role of neutralizing antibodies by sVNT after two doses of BNT162b2 mRNA vaccine in a cohort of Italian healthcare workers. Clin Chem Lab Med 2022. [PMID: 35303766 DOI: 10.1515/cclm-2022-0170] [Reference Citation Analysis]
14 Bongiovanni M, Liuzzi G, Schiavon L, Gianturco L, Giuliani G. Evaluation of the immune response to COVID-19 vaccine mRNA BNT162b2 and correlation with previous COVID-19 infection. J Clin Virol 2021;143:104962. [PMID: 34488067 DOI: 10.1016/j.jcv.2021.104962] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Noll J, Reichert M, Dietrich M, Riedel JG, Hecker M, Padberg W, Weigand MA, Hecker A. When to operate after SARS-CoV-2 infection? A review on the recent consensus recommendation of the DGC/BDC and the DGAI/BDA. Langenbecks Arch Surg. [DOI: 10.1007/s00423-022-02495-8] [Reference Citation Analysis]
16 Elhassan M, Ahmad H, Mohamed M, Saidahmed O, Elhassan AE. From Muscles to Wires: Report of Two Cases and Literature Review on COVID-19 Vaccination and Cardiac Conduction Disturbance. Cureus 2021;13:e18805. [PMID: 34796078 DOI: 10.7759/cureus.18805] [Reference Citation Analysis]
17 Mazzoleni L, Zovi A, Borsino C, D'Angelo C. Medicine shortages in the hospital setting: analysis of the trend in five Italian centres during the three waves of the SARS-CoV-2 pandemic. Eur J Hosp Pharm 2021:ejhpharm-2021-003066. [PMID: 34663585 DOI: 10.1136/ejhpharm-2021-003066] [Reference Citation Analysis]
18 Schöni D, Halatsch M, Alfieri A. The impact of reduced operating room capacity on the time delay of urgent surgical care for neurosurgical patients during the COVID-19 pandemic. Interdisciplinary Neurosurgery 2022;29:101544. [DOI: 10.1016/j.inat.2022.101544] [Reference Citation Analysis]
19 Cai F, Shou X, Ye Q. Epidemiological Study on Mycoplasma pneumoniae and Chlamydia pneumoniae Infection of Hospitalized Children in a Single Center During the COVID-19 Pandemic. Front Cell Infect Microbiol 2022;12:843463. [DOI: 10.3389/fcimb.2022.843463] [Reference Citation Analysis]
20 Lobo AP, Pinheiro RS, Rocha MS, Oliveira PB, de Araújo WN. Unexpected slowdown in the decline of tuberculosis mortality rates in Brazil from 1997 to 2017: an ecological study. Trans R Soc Trop Med Hyg 2021:trab134. [PMID: 34549302 DOI: 10.1093/trstmh/trab134] [Reference Citation Analysis]
21 Mosteiro-Miguéns DG, Roca DB, Domínguez-Martís EM, Vieito-Pérez N, Álvarez-Padín P, Novío S. Attitudes and Intentions toward COVID-19 Vaccination among Spanish Adults: A Descriptive Cross-Sectional Study. Vaccines (Basel) 2021;9:1135. [PMID: 34696243 DOI: 10.3390/vaccines9101135] [Reference Citation Analysis]
22 Chen B, Wang M, Huang X, Xie M, Pan L, Liu H, Liu Z, Zhou P. Changes in Incidence of Notifiable Infectious Diseases in China Under the Prevention and Control Measures of COVID-19. Front Public Health 2021;9:728768. [PMID: 34722440 DOI: 10.3389/fpubh.2021.728768] [Reference Citation Analysis]
23 Belu A, Trandafir LM, Țarcă E, Cojocaru E, Frăsinariu O, Stârcea M, Moscalu M, Tiutiuca RC, Luca AC, Galaction A. Variations in Biochemical Values under Stress in Children with SARS-CoV-2 Infection. Diagnostics 2022;12:1213. [DOI: 10.3390/diagnostics12051213] [Reference Citation Analysis]
24 Franchi C, Giacalone E, Di Giovanni D, Moramarco S, Carestia M. Biological Risk in Italian Prisons: From the COVID-19 Management to the Development of a Standardized Model for Emergency Response. Int J Environ Res Public Health 2021;18:10353. [PMID: 34639653 DOI: 10.3390/ijerph181910353] [Reference Citation Analysis]
25 Carneiro AC, de Pinho GS, Belo JV, Bolonhini S, Carneiro Neto MB, Mallet Toueg A, Fernandes AG. Outcomes of telemedicine care during the COVID-19 pandemic: Experience from an intervention program designed for vulnerable population in Brazil. J Telemed Telecare 2022;:1357633X221089151. [PMID: 35321612 DOI: 10.1177/1357633X221089151] [Reference Citation Analysis]